Pharmaceutical composition comprising pioglitazone and glibenclamide or glimepiride

摘要

Pharmaceutical composition comprising an insulin sensitivity enhancer, such as pioglitazone or pharmaceutically acceptable salt thereof, in combination with insulin secretion enhancer selected from glibenclamide and glimepiride and use thereof for the manufacture of a medicament for the treatment or prophylaxis of diabetes or diabetic complications.